Gene expression analysis of lung and breast cancers has recently provided insight as, in addition to YAP1 activation, embryonic stem cell (ESC) signatures are significantly elevated in human tumours lacking RASSF1A (Pefani et al, 2016). The gene discussed is RASSF1; the disease is neoplasm.